News

FTI Consulting Celebrates Record Earnings in Third Quarter

FTI Consulting Celebrates Record Earnings in Third Quarter

FTI Consulting Achieves Record Revenues in Third Quarter

FTI Consulting, Inc. (NYSE: FCN) recently announced outstanding financial results for the third quarter of 2025, reflecting a commitment to excellence in its consulting services. The company reported revenues of $956.2 million for the quarter, an increase of 3.3% compared to $926.0 million in the same period last year. This growth was bolstered by remarkable performances in the Corporate Finance & Restructuring and Forensic and Litigation Consulting segments.

Strong Earnings Per Share Growth

In addition to revenue growth, FTI Consulting celebrated a significant leap in earnings per share (EPS), which reached $2.60. This marks an impressive 41% increase from $1.85 registered in the previous year. Such robust growth underscores the company's efficient operational management and strategic initiatives to enhance profitability.

Operational Insights: Driving Factors Behind Growth

The successful quarter was influenced by various operational factors. FTI Consulting's positive revenue trajectory was primarily driven by high demand for its restructuring and transaction services, alongside elevated billing rates in its Corporate Finance & Restructuring arm. Despite challenges in its Economic Consulting and Technology divisions, the overall growth of the firm reflects its resilience and adaptability in a competitive market.

Financial Health and Share Repurchase Program

FTI Consulting has displayed significant financial health, showcasing net cash from operating activities at $201.9 million for the three months ended September 30, 2025. Although this is a slight decrease from $219.4 million in the same period last year, it highlights consistent cash generation capabilities. The company also repurchased 1,425,644 shares of its common stock during the last quarter, reflecting commitment to returning value to shareholders. As of September 30, 2025, about $75.3 million remains available for further stock repurchases under the company's ongoing program.

2025 Financial Guidance Adjusted

As a result of the successful quarter, FTI Consulting has revised its full-year guidance for 2025. The company now expects revenues between $3.685 billion and $3.735 billion, with an EPS range of $7.62 to $8.12, reflecting confidence in its growth trajectory and operational strategies.

Segment Performance Breakdown

Corporate Finance & Restructuring

The Corporate Finance & Restructuring segment reported revenues of $404.9 million, an 18.6% increase from the previous year. This success is attributed to heightened demand for services pertaining to transformations in business strategy and restructuring initiatives.

Forensic and Litigation Consulting

In the Forensic and Litigation Consulting segment, revenues surged to $194.7 million, an improvement of 15.4%. This growth was attributed to increased bill rates alongside heightened demand for risk management and litigation services.

Economic Consulting

Conversely, the Economic Consulting segment faced challenges, with revenues falling to $173.1 million, representing a 22% decrease. This decline was largely prompted by a reduction in demand for non-merger and acquisition-related antitrust services.

Technology

The Technology segment also reported a revenue decrease to $94.1 million, down 14.8% compared to last year, reflecting competitive market dynamics and reduced demand for specific services.

Strategic Communications

The Strategic Communications segment had a strong showing, with a revenue increase of 7.4% to $89.4 million, due to growing needs for corporate reputation management services.

Looking Ahead: What’s Next for FTI Consulting

Looking forward, FTI Consulting remains poised for further growth as it seeks to leverage its expertise to navigate emerging market trends. The company’s CEO, Steven H. Gunby, emphasized the importance of investing in talent and services to support clients through transformational periods. FTI Consulting is determined to sustain its momentum and deliver substantial value to its stakeholders.

Frequently Asked Questions

What are the recent financial results reported by FTI Consulting?

FTI Consulting reported record revenues of $956.2 million for the third quarter of 2025, with EPS reaching $2.60.

How has FTI Consulting's stock repurchase program progressed?

The company repurchased 1,425,644 shares at an average price of $164.18, with approximately $75.3 million left for future buybacks.

What are the expectations for FTI Consulting's financial performance in 2025?

FTI Consulting has updated its guidance for 2025, projecting revenues to be between $3.685 billion and $3.735 billion.

Which segment of FTI Consulting performed the best?

The Corporate Finance & Restructuring segment outperformed, generating $404.9 million in revenue, up 18.6% from last year.

What challenges did FTI Consulting face this quarter?

The Economic Consulting and Technology segments reported revenue declines due to decreased demand in their respective service areas.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Darden Faces Class Action Over Reimbursement Failures

Updated Category News Views 251

Class Action Puts Darden Restaurants in Legal Hot Seat Darden Restaurants, Inc. is staring down the barrel of a lawsuit that's as fiery as a grill on a Saturday night rush. The legal cavalry from Blumenthal Nordrehaug Bhowmik De Blouw LLP has stormed in with a class action complaint, aiming dead center at Darden for allegedly breaching the California Labor Code. In plain...

Continue Reading
Master Sommeliers and Italian Producers Clash on Wine Lists

Updated Category News Views 166

Wines Jockeying for New York’s Coveted Lists Alright, picture a stage set up in New York City like an arena. But instead of gladiators, you've got master sommeliers on one side and Italian wine producers on the other, each armed with their own arguments. They're locked in a battle over what it really takes to get a bottle imbedded on a New York City's prestigious wine...

Continue Reading
Axon Body 5: A Leap Forward in AI for Public Safety

Updated Category News Views 284

Axon Raises the Stakes with Body 5 Camera Boy, oh boy, Axon's dropped a bombshell with the Body 5. We're talking a colossal leap into the AI era for public safety, and if you're in the biz, you can't just shrug this one off. We're looking at 25 times the AI processing power compared to Axon's old units. That's right, I said twenty-five. Real-time situational awareness in...

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 35

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading
ST Engineering iDirect, MBSat Forge Middle East Satellite Hub

Updated Category News Views 118

Satellite Services Take Off in the Middle East Never thought the day would come where the Middle East is on the threshold of leapfrogging satellite tech, but here we are. ST Engineering iDirect just locked arms with MBSat—yep, that's part of the Mohammed Al Barwani Group—to birth a next-gen satellite connectivity service hub in Oman and across surrounding areas....

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 79

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
ASTS Faces Crucial Deadline Amidst Legal Turmoil

Updated Category News Views 176

Ah, the ticking clock in the world of stock investments, where a nifty little thing called a class action lawsuit can flip your investment on its head. Right now, AST SpaceMobile (NASDAQ: ASTS) investors are staring down the barrel of one such lawsuit. With the November 13, 2026, deadline looming, it's time to sort the facts from the muck. Pins and Needles for ASTS...

Continue Reading
Amgen's IMDELLTRA® Shows Promise in SCLC Battle

Updated Category News Views 389

Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 145

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Apalutamide Boosts Outlook for Prostate Cancer Treatment

Updated Category News Views 90

Fresh Findings on High-Risk Prostate Cancer Treatments In an industry that often feels like a game of chess, Johnson & Johnson's recent news unveils another one of their strategic moves with the announcement of breakthrough results from their Phase 3 PROTEUS substudy. Turns out, ERLEADA®, their apalutamide treatment, isn't just another pawn; it's a potential...

Continue Reading

Top 5 Most Recently Viewed Articles

Boost Your Pup's Health with Routine and Technology

Updated Category News Views 121

Healthy Pet Routines Start with Pawfit Trackers As seasons change, it's a great opportunity to refresh not only our human routines but also those of our beloved pets. Pets thrive on consistency and routine, which contributes to their physical and mental well-being. Not only does implementing a structured schedule benefit pets, but it reinforces the bond we share with them...

Continue Reading
Revolutionizing Connectivity: World Mobile's Bold Move in Mozambique

Updated Category News Views 142

World Mobile’s Groundbreaking Initiative in Mozambique World Mobile, recognized as the sixth-largest blockchain-based connectivity company, has announced an important milestone by transitioning Mozambique's first national TV White Space (TVWS) spectrum database into the hands of local authorities, partnering with the Instituto Nacional de Comunicações de Moçambique...

Continue Reading
Ponce Bank Expands with New Coral Gables Office Offering Services

Updated Category News Views 167

Ponce Financial Group, Inc. opened its first representative office in Florida back in 2024, setting up shop at 1600 Ponce de Leon Drive in Coral Gables. This wasn't just a casual expansion; it marked a strategic move into a bustling Miami suburb packed with potential customers who either run businesses there or flock to the area during winter months. The whole idea was to...

Continue Reading
Cough Assist Devices Market Set for Expansive Growth Ahead

Updated Category News Views 150

Cough Assist Devices Market Analysis The cough assist devices market is poised for substantial growth, with projections indicating it could soar to USD 547.99 million in the upcoming years. This remarkable increase is expected to occur at a compound annual growth rate (CAGR) of 7.24% from its 2024 valuation of USD 275.99 million, as reported by a recent study from a...

Continue Reading
Transforming Futures Analysis with DOM Heatmap Integration

Updated Category News Views 189

Unveiling New Market Analysis Tools dxFeed, a frontrunner in market data solutions and index management, has partnered with ATAS to introduce a transformative approach to futures market analysis by offering historical DOM Levels, also known as Heatmap data. This innovative collaboration harnesses the power of historical order book liquidity data from major exchanges,...

Continue Reading